JAZZ PDUFA decision: a positive outcome, +5.6%

On June 15, 2020, Jazz Pharmaceuticals plc reached its PDUFA decision. The result was a positive outcome, and the stock moved +5.6% in the window around the event. It had already run -5.8% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.